Abstract
SZ1676,1-[3α,17β-bis(acetyloxy)-2β-(1,4-dioxa-8-azaspiro[4.5]dec-8-yl)-5α-androstan-16β-yl]-1-(2-propenyl)pyrrolidinium.Br, and its 3-OH derivative, SZ1677, are steroid type, nondepolarizing muscle relaxants(MR) under investigation. Rocuronium,1 another steroid type nondepolarizing MR, has been recently introduced into clinical practice. The present study has been undertaken as a part the characterization of the pharmacological profile of these MR.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Foldes FF, Nagashima H, Nguyen HO et al. Anesthesiology 75:191–96, 1991.
Foldes FF, Deery A. In: Handbook of Experimental Pharmacology (Kharkevich DA, Ed), Springer-Verlag, Berlin, 1986. pp 225–31.
Thut PD, Lure TH, Cordes CT, Foldes FF. Anesth Analg 78:S438, 1994.
Foldes FF, Tuba Z, Nagashima H et al. Anesth Analg 78:S117, 1994.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Japan
About this paper
Cite this paper
Chaudhry, I.A., Foldes, F.F., Nagashima, H. (1995). The Protein Binding of SZ1676, SZ1677 and Rocuronium and Their Inhibitory Effect on Human Cholinesterases. In: Fukushima, K., Ochiai, R. (eds) Muscle Relaxants. Springer, Tokyo. https://doi.org/10.1007/978-4-431-66896-1_81
Download citation
DOI: https://doi.org/10.1007/978-4-431-66896-1_81
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-66898-5
Online ISBN: 978-4-431-66896-1
eBook Packages: Springer Book Archive